EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Discovery of antitumor effects of leczymes

Takeo Tatsuta, Masahiro Hosono iD

Glycoconjugate Journal · 2022-04 · 39 (2) · 157-165

DOI: 10.1007/s10719-021-10033-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Glycoconjugate Journal, online erschienen am 23.01.2022. Verfasst von Takeo Tatsuta und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cell Recognition, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, 4-4-1 Komatsushima, …. Hauptthemen laut MEDLINE: Antineoplastic Agents, Apoptosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 85 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sialic-acid binding lectin from bullfrog (Rana catesbeiana) eggs, cSBL, is a cytotoxic ribonuclease (RNase) belonging to the RNase A superfamily. cSBL is cytotoxic to tumor cells, such as malignant pleural mesothelioma by inducing apoptotic cell death caused by the degradation of RNA in tumor cells. In addition, we have reported some data that cSBL could be involved in the endoplasmic reticulum stress pathway, and it was also assumed to cause apoptotic cell death. The most significant property of cSBL is its specificity toward malignant cells. Furthermore, since the antitumor activity of cSBL was confirmed by in vivo experiments using mouse xenograft models, it is expected to be a candidate for clinical chemotherapy. Here, we summarize the history of cSBL, alternatively called "leczyme," with its present and future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsApoptosisAnimalsHumansLectinsMiceRana catesbeianaRibonucleases

Stichwörter der Autor:innen

Antitumor activityApoptosisLectinRibonucleaseSialic acids

Substanzen

Antineoplastic AgentsLectinsRibonucleases

Autor:innen und Institutionen

  • Division of Cell Recognition, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sendai, 981-8558, Japan.
  • Division of Cell Recognition, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sendai, 981-8558, Japan. mhosono@tohoku-mpu.ac.jp.

ORCID-Profile: Masahiro Hosono

Zitieren

APA

Tatsuta, T., & Hosono, M. (2022). Discovery of antitumor effects of leczymes. Glycoconjugate Journal, 39(2), 157-165. https://doi.org/10.1007/s10719-021-10033-9

Vancouver

Tatsuta T, Hosono M. Discovery of antitumor effects of leczymes. Glycoconjugate Journal. 2022;39(2):157-165. doi:10.1007/s10719-021-10033-9

BibTeX
@article{Tatsuta2022,
  author = {Tatsuta, Takeo and Hosono, Masahiro},
  title = {Discovery of antitumor effects of leczymes},
  journal = {Glycoconjugate Journal},
  year = {2022},
  volume = {39},
  number = {2},
  pages = {157--165},
  doi = {10.1007/s10719-021-10033-9}
}
Kostenlos starten →